Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H.P. Acthar Gel in Uveitis with Glaucoma
NCT02764697Phase 4Completed
- Sponsor
- Tampa Bay Uveitis Center
- Start
- Jun 2016
- Primary completion
- Dec 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of repository corticotropin injection in noninfectious uveitis (NIU), scleritis, macular edema, sponsored by Tampa Bay Uveitis Center. Started Jun 2016; status: completed.
02
Drugs
repository corticotropin injection
03
Conditions
noninfectious uveitis (NIU)scleritismacular edema
Beyond the preview
Go deeper on NCT02764697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02764697.